|
Visugromab (CTL-002) Clinical Trials
1 actively recruiting trial across 1 location
No change since July 2026
Pipeline
Phase 2/3: 1
Top Sponsors
- CatalYm GmbH1
Indications
- Cancer-associated Cachexia1
- Weight Loss1
- Cancer1
Norwich, Connecticut1 trial
Visugromab in Cachexia International Trial
Eastern Connecticut Hematology & Oncology
Phase 2/3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.